作者: Yoav Avidor , Nicola J. Mabjeesh , Haim Matzkin
DOI: 10.1097/01.SMJ.0000066654.35645.F7
关键词:
摘要: New biotechnology and drug discovery technologies are facilitating the rapid expansion of clinical chest, empowering clinicians with a better understanding disease as well novel modalities for treating patients. Important research tools themes include genomics, proteomics, ligand-receptor interaction, signal transduction, rational design, biochips, microarrays. Emerging classes monoclonal antibodies, cancer vaccines, gene therapy, antisense strands, enzymes, proteins. In this article, we review these topics illustrate their potential impact by presenting an overview promising drugs in pipeline. Clinicians who use treatments must become familiar trends.